MENU
GLPG
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Galapagos (GLPG) Earnings Date & Reports

Galapagos NV is a fully integrated biotechnology company with operations in Europe and the United States, dedicated to developing medicines focusing on oncology and immunology... Show more

Industry: #Biotechnology
A.I. Advisor
published Earnings

GLPG is expected to report earnings to fall 86.50% to -47 cents per share on February 24

Galapagos GLPG Stock Earnings Reports
Q4'25
Est.
$-0.48
Q3'25
Missed
by $3.19
Q2'25
Missed
by $1.62
Q1'25
Missed
by $2.57
Q4'24
Beat
by $0.02
The last earnings report on November 05 showed earnings per share of -353 cents, missing the estimate of -35 cents. With 236.23K shares outstanding, the current market capitalization sits at 2.16B.
View a ticker or compare two or three
GLPG
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. GLPG showed earnings on November 05, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a manufacturer of pharmaceutical products

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
Generaal De Wittelaan L11 A3
Phone
+32 15342900
Employees
1123
Web
https://www.glpg.com